Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Even The Discounted Buyout Value Of PVCT Is HUGE

Seeking Alpha rejected the 4th article in the series. Apparently, there were too many actual numbers about the potential business, among other things. They have stricter guidelines about Biotech than anything else, presumable so they don't get sued.

So I am making the report available for free download on my site, here.

Disclosure: I am long PVCT.